Lands' End (LE) Competitors $15.30 +0.42 (+2.82%) Closing price 09/11/2025 04:00 PM EasternExtended Trading$15.46 +0.15 (+1.01%) As of 07:31 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock LE vs. GRDN, ARHS, RVLV, NEGG, TDUP, SPH, RERE, JMIA, GCT, and HEPSShould you be buying Lands' End stock or one of its competitors? The main competitors of Lands' End include Guardian Pharmacy Services (GRDN), Arhaus (ARHS), Revolve Group (RVLV), Newegg Commerce (NEGG), ThredUp (TDUP), Suburban Propane Partners (SPH), ATRenew (RERE), Jumia Technologies (JMIA), GigaCloud Technology (GCT), and D-MARKET Electronic Services & Trading (HEPS). These companies are all part of the "retail" industry. Lands' End vs. Its Competitors Guardian Pharmacy Services Arhaus Revolve Group Newegg Commerce ThredUp Suburban Propane Partners ATRenew Jumia Technologies GigaCloud Technology D-MARKET Electronic Services & Trading Guardian Pharmacy Services (NYSE:GRDN) and Lands' End (NASDAQ:LE) are both small-cap retail companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, dividends, risk, valuation, analyst recommendations, institutional ownership and media sentiment. Do insiders and institutionals hold more shares of GRDN or LE? 37.5% of Lands' End shares are held by institutional investors. 63.7% of Guardian Pharmacy Services shares are held by company insiders. Comparatively, 1.7% of Lands' End shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Do analysts prefer GRDN or LE? Guardian Pharmacy Services presently has a consensus target price of $25.67, suggesting a potential downside of 15.12%. Given Guardian Pharmacy Services' stronger consensus rating and higher possible upside, analysts plainly believe Guardian Pharmacy Services is more favorable than Lands' End.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Guardian Pharmacy Services 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Lands' End 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media favor GRDN or LE? In the previous week, Lands' End had 25 more articles in the media than Guardian Pharmacy Services. MarketBeat recorded 28 mentions for Lands' End and 3 mentions for Guardian Pharmacy Services. Lands' End's average media sentiment score of 0.26 beat Guardian Pharmacy Services' score of 0.10 indicating that Lands' End is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardian Pharmacy Services 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Lands' End 4 Very Positive mention(s) 1 Positive mention(s) 10 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Is GRDN or LE more profitable? Lands' End has a net margin of 0.46% compared to Guardian Pharmacy Services' net margin of -6.90%. Lands' End's return on equity of 5.32% beat Guardian Pharmacy Services' return on equity.Company Net Margins Return on Equity Return on Assets Guardian Pharmacy Services-6.90% -52.41% -24.17% Lands' End 0.46%5.32%1.54% Which has stronger earnings and valuation, GRDN or LE? Lands' End has higher revenue and earnings than Guardian Pharmacy Services. Guardian Pharmacy Services is trading at a lower price-to-earnings ratio than Lands' End, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGuardian Pharmacy Services$1.23B1.56-$87.29M-$1.52-19.89Lands' End$1.36B0.34$6.23M$0.13117.69 SummaryLands' End beats Guardian Pharmacy Services on 10 of the 15 factors compared between the two stocks. Get Lands' End News Delivered to You Automatically Sign up to receive the latest news and ratings for LE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LE vs. The Competition Export to ExcelMetricLands' EndRETAIL IndustryRetail SectorNASDAQ ExchangeMarket Cap$454.09M$454.09M$27.71B$10.07BDividend YieldN/AN/A173.91%4.62%P/E Ratio85.0085.0021.1526.20Price / Sales0.340.347.8591.86Price / Cash8.708.7064.8459.91Price / Book2.072.074.856.28Net Income$6.23M$6.23M$875.30M$270.85M7 Day Performance6.25%6.25%2.32%3.58%1 Month Performance16.70%16.70%6.73%6.67%1 Year Performance8.43%8.43%23.06%27.74% Lands' End Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LELands' End0.7866 of 5 stars$15.30+2.8%N/A+11.0%$454.09M$1.36B85.004,400Trending NewsEarnings ReportAnalyst RevisionHigh Trading VolumeGRDNGuardian Pharmacy Services0.6502 of 5 stars$26.28+0.5%$25.67-2.3%N/A$1.66B$1.33B-17.293,400News CoverageARHSArhaus1.9422 of 5 stars$11.73-0.2%$10.83-7.6%+2.7%$1.65B$1.27B23.462,550Positive NewsRVLVRevolve Group3.5737 of 5 stars$22.38-1.4%$27.40+22.4%+5.9%$1.60B$1.13B36.101,632Positive NewsNEGGNewegg Commerce1.6937 of 5 stars$41.93-15.3%N/A+150.7%$1.60B$1.24M0.002,200TDUPThredUp3.5673 of 5 stars$10.82-3.4%$13.00+20.1%+1,228.1%$1.33B$260.03M-22.081,630News CoverageSPHSuburban Propane Partners1.6448 of 5 stars$18.74+0.7%N/A+4.8%$1.23B$1.33B12.663,098Positive NewsREREATRenew2.1961 of 5 stars$4.72+1.1%N/A+80.8%$1.15B$18.55B39.342,096JMIAJumia Technologies0.7047 of 5 stars$8.62-5.6%$4.75-44.9%+110.8%$1.06B$164.02M0.002,163GCTGigaCloud Technology2.0408 of 5 stars$26.47+1.3%$24.00-9.3%+57.2%$997.13M$1.16B7.951,561Insider TradeShort Interest ↓HEPSD-MARKET Electronic Services & Trading2.2817 of 5 stars$2.76-1.8%$3.50+26.8%+18.8%$887.01M$1.74B-15.333,743News CoveragePositive NewsShort Interest ↓ Related Companies and Tools Related Companies Guardian Pharmacy Services Alternatives Arhaus Alternatives Revolve Group Alternatives Newegg Commerce Alternatives ThredUp Alternatives Suburban Propane Partners Alternatives ATRenew Alternatives Jumia Technologies Alternatives GigaCloud Technology Alternatives D-MARKET Electronic Services & Trading Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LE) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCollege grad makes $64,000 a monthIt's easy to feel like you've missed out on the biggest stock market boom of the century. But if you want t...Stansberry Research | SponsoredUrgent: $3,452.50 a Month in Passive "AI Equity Checks"The U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | Sponsored2013 Bitcoin miner reveals his trading system (free)There are 18,347 cryptocurrencies in the market right now. 99% of them will fail. And trying to pick winner...Crypto Swap Profits | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lands' End, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lands' End With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.